The action spectrum for vitamin D3: initial skin reaction and prolonged exposure.

Vitamin D3 photosynthesis in the skin is formulated as a set of reaction equations, including side-reactions to lumisterol, tachysterol and toxisterols, and the accompanying reverse reactions, isomerisation of previtamin D3 to vitamin D3 and photodegradation of vitamin D3. The solution of this set is given for the stationary irradiance spectrum. The effective action spectrum for the instantaneous vitamin D3 production changes shape as a function of exposure, and therefore, no single action spectrum can be used. We assessed the action spectrum for unexposed skin and for skin that has been exposed to 7.5 Standard Erythemal Doses (SED). We constructed two new estimates: (1) the RIVM action spectrum, based on absorption spectra, quantum yields and skin transmission spectra, and (2) the modified QUT action spectrum, which is adjusted for self-absorption and skin transmission. For previously unexposed skin, the modified QUT action spectrum gives a qualitatively similar, but larger estimate than the RIVM action spectrum. We have not been able to solve the lack of quantitative agreement between the vitamin D production estimates from the three action spectrum estimates (RIVM, modified QUT and CIE). All new action spectra have stronger emphasis on the short wavelengths than the CIE action spectrum. We showed that, for wavelengths larger than 300 nm, the bandwidth that was used in the experiment that formed the basis of the CIE action spectrum, gives a red-shift of about 1 nm. Generally, with the formation of previtamin D3, the return reaction to provitamin D3 limits the production of vitamin D3. After some exposure, the new action spectrum has negative values for the longer wavelengths in the UVB. For the RIVM action spectrum, this happens after 7.5 SED, for the modified QUT action spectrum already after 1.25 SED, and after 7.5 SED the net production rate is largely cancelled. Thus prolonged exposure of previously unexposed skin saturates vitamin D3 formation. For maximum vitamin D production after 1.25 SED, sunscreens should block wavelengths larger than 310 nm. Sunscreens that block only UVB could result in reduction in vitamin D production after prolonged exposure, or even a destruction of vitamin D that has just been formed.

Skin cancer risks avoided by the Montreal Protocol--worldwide modeling integrating coupled climate-chemistry models with a risk model for UV.

The assessment model for ultraviolet radiation and risk "AMOUR" is applied to output from two chemistry-climate models (CCMs). Results from the UK Chemistry and Aerosols CCM are used to quantify the worldwide skin cancer risk avoided by the Montreal Protocol and its amendments: by the year 2030, two million cases of skin cancer have been prevented yearly, which is 14% fewer skin cancer cases per year. In the "World Avoided," excess skin cancer incidence will continue to grow dramatically after 2030. Results from the CCM E39C-A are used to estimate skin cancer risk that had already been inevitably committed once ozone depletion was recognized: excess incidence will peak mid 21st century and then recover or even super-recover at the end of the century. When compared with a "No Depletion" scenario, with ozone undepleted and cloud characteristics as in the 1960s throughout, excess incidence (extra yearly cases skin cancer per million people) of the "Full Compliance with Montreal Protocol" scenario is in the ranges: New Zealand: 100-150, Congo: -10-0, Patagonia: 20-50, Western Europe: 30-40, China: 90-120, South-West USA: 80-110, Mediterranean: 90-100 and North-East Australia: 170-200. This is up to 4% of total local incidence in the Full Compliance scenario in the peak year.

Know your standard: clarifying the CIE erythema action spectrum.

The standard erythema action spectrum provides an internationally accepted representation of the erythema-inducing effectiveness of wavelengths in the UV part of the spectrum. The action spectrum forms the basis of the UV index used for public health information, defines the standard erythema dose unit and the minimum erythema dose and is the default response spectrum aspired to by a range of UV radiometer manufacturers. However, there are several versions of this erythema action spectrum in use, and only one of them has been endorsed as a standard. While the differences in erythemally weighted radiation incurred by choice of action spectrum will be no more than a few percent, this uncertainty is unnecessary. Here we detail the differences in the different versions of erythema action spectra, illustrate the resulting effects in quantifying UV doses and encourage readers to use only the standard version of the action spectrum in the future.

Spatial- and time-explicit human damage modeling of ozone depleting substances in life cycle impact assessment.

Depletion of the stratospheric ozone layer is mainly caused by emissions of persistent halocarbons of anthropogenic origin. The resulting increase of solar ultraviolet radiation at the Earth's surface is associated with increased exposure of humans and increased human health damage. Here we assessed the change in human health damage caused by three types of skin cancer and cataract in terms of (healthy) years of life lost per kiloton emission reduction of an ozone-depleting substance (ODS). This so-called characterization factor is used in Life Cycle Assessments (LCAs). Characterization factors are provided for the emissions of five chlorofluorocarbons, three hydrochlorofluorocarbons, three (bromine-containing) halons, carbon tetrachloride, methyl chloroform, and anthropogenic emissions of methyl bromide. We employed dynamic calculations on a global scale for this purpose, taking physical and social geographic data into account such as skin tones, population density, average age, and life expectancy. When emission rates of all ODSs in 2007 are multiplied by our characterization factors, the resulting number of years of life lost may be a factor of 5 higher than reported previously. This increase is merely explained through the global demographic development until 2100 we took into account.

Calculations of the human vitamin D exposure from UV spectral measurements at three European stations.

The health benefits of solar UVB and vitamin D in reducing the risk of cancer and several other diseases have been well documented in recent years. In this study, quality-checked spectral UV irradiance measurements from three European stations (Jokioinen, Finland; Bilthoven, The Netherlands; and Thessaloniki, Greece) are used and the vitamin D effective dose (VDED) is calculated. The maximum average daily VDED is measured during the second half of June and it is up to 250 times higher than the corresponding winter minimum value. At each site, a polynomial fit between the VDED and the erythemal dose rates is proposed. The average VDED rates at local noon exceed a detection threshold value for the cutaneous production of vitamin D at Thessaloniki and Bilthoven throughout the year. The proposed standard vitamin dose cannot be attained, even for skin types I-III and exposure time of 60 minutes around local noon, under physiological atmospheric conditions at Bilthoven and Jokioinen during 3 and 4 months respectively. The daily VDED values, using the CIE action spectrum, are higher from 2% and 8% during summer and winter respectively at all sites, compared with those derived by the action spectrum proposed by MacLaughlin et al. (Science, 1982, 216, 1001-1003). These differences are comparable with the uncertainty of spectral measurements.

Europe's darker atmosphere in the UV-B.

Irradiation in the ultraviolet wavelength range is found to be up to 50% lower in the European summer compared to sites with comparable latitudes in New Zealand. We have developed a method to quantitatively attribute the causes for such differences between sites by analysis of spectra. We conclude that these large differences are caused mainly by differences in total ozone, cloudiness, aerosol loading and Sun-Earth separation. The relative contribution of clouds varies from year to year and it is site dependent. Averaged over several years we find a strong latitudinal gradient of the cloud impact within Europe, with much less cloud attenuation in southern Europe. Due to the differences in total ozone and aerosol loading, the UV-B levels are generally lower in Europe compared to New Zealand. It is likely that inter-hemispheric differences will change in coming decades due to a combination of changes in ozone concentrations, air pollution and cloudiness as a result of climate change. However, since the future evolution of these major parameters is highly uncertain, the magnitude and even the sign of such changes are not known yet.

Variability of UV irradiance in Europe.

The diurnal and annual variability of solar UV radiation in Europe is described for different latitudes, seasons and different biologic weighting functions. For the description of this variability under cloudless skies the widely used one-dimensional version of the radiative transfer model UVSPEC is used. We reconfirm that the major factor influencing the diurnal and annual variability of UV irradiance is solar elevation. While ozone is a strong absorber of UV radiation its effect is relatively constant when compared with the temporal variability of clouds. We show the significant role that clouds play in modifying the UV climate by analyzing erythemal irradiance measurements from 28 stations in Europe in summer. On average, the daily erythemal dose under cloudless skies varies between 2.2 kJ m(-2) at 70 degrees N and 5.2 kJ m(-2) at 35 degrees N, whereas these values are reduced to 1.5-4.5 kJ m(-2) if clouds are included. Thus clouds significantly reduce the monthly UV irradiation, with the smallest reductions, on average, at lower latitudes, which corresponds to the fact that it is often cloudless in the Mediterranean area in summer.

Health effects from stratospheric ozone depletion and interactions with climate change.

The potential health effects of elevated levels of ambient UV-B radiation are diverse, and it is difficult to quantify the risks, especially as they are likely to be considerably modified by human behaviour. Nevertheless epidemiological and experimental studies have confirmed that UV radiation is a definite risk factor for certain types of cataract, with peak efficacy in the UV-B waveband. The causal link between squamous cell carcinoma and cumulative solar UV exposure has been well established. New findings regarding the genetic basis of skin cancer, including studies on genetically modified mice, have confirmed the epidemiological evidence that UV radiation contributes to the formation of basal cell carcinomas and cutaneous melanomas, For the latter, animal models have demonstrated that UV exposure at a very young age is more detrimental than exposure in adulthood. Although suppression of certain immune responses has been recognised following UV exposure, the impact of this suppression on the control of infectious and autoimmune diseases is largely unknown. However, studies on several microbial infections have indicated significant consequences in terms of symptoms or reactivation of disease. The possibility that the immune response to vaccination could be depressed by UV-B exposure is of considerable concern. Newly emerging possibilities regarding interactions between ozone depletion and global climate change further complicate the risk assessments for human health but might result in an increased incidence of cataracts and skin cancer, plus alterations in the patterns of certain categories of infectious and other diseases.

Exposure to solar ultraviolet radiation in young Dutch children: assessment by means of a 6-week retrospective questionnaire.

We designed a 6-week retrospective questionnaire on sunlight exposure. Estimation of the short-term exposure to sunlight is important for observational human studies concerning the effects of ultraviolet radiation (UVR) on the human immune system and related resistance to infections. This questionnaire was given to the parents of 1672 1-year-old children in the Netherlands who participated in a birth cohort study. We evaluated the questionnaire and estimated the personal 6-week cumulative exposure to solar UVR. Only 910 questionnaires (54.4%) were filled out completely and consistently. This suggests that reporting data on children's outdoor exposure, even for the recent past, is often difficult. The data from these questionnaires indicated that the crude number of reported outdoor hours was enough to obtain a relative estimate of the individual exposure to ambient UVR, but that weighting for the effect of clothing was essential for the classification of the systemic UVR dosage received. Sunny weeks in the Netherlands in 1998, as were established by independent measurements of the levels of ambient UVR, vacations abroad, and sunburn, were associated with a comparatively high mean estimated exposure. These results support the suitability of the questionnaire for classifying the participants with respect to their short-term exposure to solar UVR.